
Martin MacLean
Martin MacLean’s principal practice areas include; drafting and global prosecution, defence and opposition, freedom-to-operate and strategic advice. In this regard, he has extensive experience in the conduct of hearings before the European Patent Office, having conducted over 100 hearings. Martin specialises in technologies such as the re-targeting of bacterial toxins, vaccines, expression systems, microbial detection assays, cytokine-based therapeutics, and agrochemicals, and represents clients ranging from UK Government and blue chip biotech companies through to spin-outs and start-ups. · Mathys & Squire LLP
About
Martin MacLean is a partner and patent attorney at Mathys & Squire with extensive experience in drafting, global prosecution, defence and opposition, freedom-to-operate work and strategic IP advice; he has conducted over 100 hearings before the European Patent Office. He specialises in life sciences and biotechnology technologies and represents clients from UK Government and blue-chip biotech companies to spin-outs and start-ups.
Practice areas
Office
Expertise
Education
- First degree (Microbial Technology), University of Warwick
- PhD, University of Warwick (research into biochemical aspects of acidophilic bacteria)
- Master's degree in IP, University of London
Admissions
- Chartered Patent Attorney
- European Patent Attorney